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Human glucose-6-phosphate dehydrogenase (G6PD) is
NADP+-dependent and catalyses the first and rate-limiting
step of the pentose phosphate shunt. Binary complexes of the
human deletion mutant, G6PD, with glucose-6-phosphate
and NADP+ have been crystallized and their structures solved
to 2.9 and 2.5 A˚, respectively. The structures are compared
with the previously determined structure of the Canton
variant of human G6PD (G6PDCanton) in which NADP
+ is
bound at the structural site. Substrate binding in G6PD is
shown to be very similar to that described previously in
Leuconostoc mesenteroides G6PD. NADP+ binding at the
coenzyme site is seen to be comparable to NADP+ binding in
L. mesenteroides G6PD, although some differences arise as a
result of sequence changes. The tetramer interface varies
slightly among the human G6PD complexes, suggesting
flexibility in the predominantly hydrophilic dimer–dimer
interactions. In both complexes, Pro172 of the conserved
peptide EKPxG is in the cis conformation; it is seen to be
crucial for close approach of the substrate and coenzyme
during the enzymatic reaction. Structural NADP+ binds in a
very similar way in the G6PD–NADP+ complex and in
G6PDCanton, while in the substrate complex the structural
NADP+ has low occupancy and the C-terminal tail at the
structural NADP+ site is disordered. The implications of
possible interaction between the structural NADP+ and G6P
are considered.
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PDB References: G6PD–
G6P, 2bhl, r2bhlsf; G6PD–
NADP+, 2bh9, r2bh9sf.
1. Introduction
Human glucose-6-phosphate dehydrogenase (G6PD; EC
1.1.1.49) is an X-linked housekeeping enzyme that catalyses
the first and rate-limiting step of the pentose phosphate shunt.
It converts -d-glucose 6-phosphate (G6P) to 6-phospho-
glucono--lactone with the reduction of NADP+ to NAPDH,
providing cells with pentoses for nucleic acid synthesis and
NADPH as the principal modulator of intracellular redox
potential. G6PD has been identified as the only NADPH-
producing enzyme that is activated during oxidative stress
(Filosa et al., 2003). In erythrocytes, the role of G6PD is
particularly important as the sole source of NADPH.
Active human G6PD exists in a rapid dimer–tetramer
equilibrium, which is affected by ionic strength and pH
(Cohen & Rosemeyer, 1969). Little is known about the
physiological significance of the interconversion. Kinetically
homogenous recombinant human G6PD has been shown
recently to obey a rapid-equilibrium random-order
mechanism (Wang et al., 2002).
Multiple sequence alignment of over 100 currently known
G6PDs from different organisms shows sequence identity
varying from 30 to 94% (data not given). The human enzyme
and Leuconostoc mesenteroides G6PD (LM G6PD), the
structures of which are known, have 35% sequence identity.
The sequence alignment reveals three conserved regions: a
nine-residue peptide (RIDHYLGKE, residues 198–206 of the
human enzyme), a nucleotide-binding fingerprint (GxxG-
GDLA, residues 38–44 of the human enzyme) and the
sequence EKPxG (residues 170–174 of the human enzyme). In
the nine-residue peptide, the aspartate, histidine and lysine
have been shown to be important in G6P binding and catalysis
in LM G6PD (Cosgrove et al., 2000) and Lys205 has been
implicated in binding and catalysis in the human enzyme
(Bautista et al., 1995). The nucleotide fingerprint has been
associated with coenzyme binding (Levy et al., 1996) and the
function of these residues has been elucidated by the struc-
tures of LM G6PD (Rowland et al., 1994; Naylor et al., 2001).
The 3 A˚ resolution structure of the human G6PD Canton
(R459L) variant (G6PDCanton) crystallized in the presence of
NADP+ and glycollate ions has been described previously (Au
et al., 2000). Human G6PD is similar to LM G6PD, with a
‘Rossmann-fold’ coenzyme-binding domain and a + domain
which forms the dimer interface (Fig. 1). The human G6PD
tetramer has 222 symmetry. The tetramer interface is small
and interactions are primarily electrostatic. No NADP+ was
found in the expected coenzyme site; ‘structural’ NADP+ was
found to bind in the + domain of G6PDCanton between the
-sheet and the C-terminus. The site is close to the dimer
interface, but all contacts are made to side-chain atoms of one
subunit. There is no structural NADP+ site in LM G6PD.
G6PD deficiency is one of the most common human genetic
defects. Common clinical manifestations include acute
haemolytic anaemia, neonatal jaundice and favism, symptoms
which are normally triggered by oxidative agents (Beutler,
1990). To date, over 150 different human G6PDmutants with a
spectrum of clinical severity have been identified. The rarer
severe variants (class I mutants) give rise to chronic
nonspherocytic haemolytic anaemia. In all cases, some resi-
dual enzyme activity is found; there is no known human null
mutant. It has recently been shown that the total loss of G6PD
activity is an embryonic lethal in mouse (Longo et al., 2002).
Levels of NAPDH are reduced in erythrocytes containing low-
activity variants (Mareni & Gaetani, 1976). Among the 71
reported class I mutants, 28 are clustered within 4.5 A˚ of the
dimer interface and the structural NADP+ site; the integrity of
these regions is important for enzyme stability and in vivo
activity.
This paper describes G6P and NADP+ complexes of the
human G6PD deletion mutant G6PD. This mutant was
created in the hope of growing higher quality crystals (Au et
al., 1999). It is not a natural variant; the 25 N-terminal residues
of human G6PD that precede the dinucleotide-binding fold
have been removed. Not only were these residues poorly
ordered in the G6PDCanton structure, but there is also very
poor conservation among species of the region N-terminal of
the Rossmann fold and great variation in length. This mutant
enzyme is here shown to have similar initial rate kinetic
properties to those of the wild type. The structures of the
G6PD complexes are described and the proteins and
structural NADP+ sites are compared with G6PDCanton (Au et
al., 2000). The coenzyme and substrate sites are compared
with those previously described in LM G6PD (Cosgrove et al.,
2000; Naylor et al., 2001). The contributions of this study to the
understanding of the kinetic mechanism and the stability of
human G6PD are discussed.
2. Materials and methods
2.1. Cloning, expression and purification of DG6PD
G6PD was constructed as described previously (Au et al.,
1999). Expression ofG6PD was carried out using the G6PD-
deficient Escherichia coli strain DF213 [(eda-zwf)15, hisG1,
rpsL115, metA28, mu+] (E. coli Stock Centre, Yale Uni-
versity). Terrific Broth (500 ml) containing ampicillin
(200 mg ml1) was inoculated with 5 ml of an overnight culture
of E. coli containing the recombinant plasmid pTrc/G6PD.
When the OD600 of the culture reached 0.7–0.8, 0.5 mM
isopropyl thio--d-galactoside was added to induce protein
expression. Expression was carried out for 16–18 h at 310 K.
Harvested cells were resuspended in 0.1M Tris–HCl pH 7.6
and 5 mM EDTA with Complete EDTA-free protease-
inhibitor cocktail (Roche) and lysed by sonication. After
centrifugation, the supernatant was loaded onto a 20,50-ADP
Sepharose column (Amersham). The enzyme was eluted with
75 mM NADP+ in 0.1M Tris–HCl pH 7.6, 5 mM EDTA and
Complete EDTA-free protease-inhibitor cocktail and
concentrated to 5 mg ml1 using Amicon stirred cells (Milli-
pore).
2.2. Measurement of initial rate kinetic parameters
The fluorimetric measurement and calculation of initial rate
kinetics parameters of G6PD were carried out as described
previously (Wang et al., 2002).
2.3. G6P-bound DG6PD in C2221
2.3.1. Crystallization. Initial screening for crystallization
conditions was carried out by hanging-drop vapour diffusion
using Molecular Dimensions Structure Screens 1 and 2.
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Figure 1
The human G6PDCanton dimer. Helices and sheet strands of the A subunit
are shown in red and green, respectively, and each of the secondary-
structure elements identified in the G6PDCanton structure is labelled. The
figure was prepared using BOBSCRIPT (Kraulis, 1991; Esnouf, 1997) and
RASTER3D (Merrit & Murphy, 1994; Bacon & Anderson, 1988), as were
all other diagrams in this paper.
Crystals were found to grow in solution 33 (0.1M Tris–HCl pH
8.5, 0.2M MgCl2, 30% PEG 4000). These conditions were
optimized using sitting-drop vapour diffusion. Drops made by
mixing equal volumes of 5 mg ml1 G6PD in elution buffer
(0.1M Tris–HCl pH 7.5, 5 mM EDTA, 75 mM NADP+),
60 mM G6P and well buffer (0.1M Tris–HCl pH 8.5, 0.2M
MgCl2, 12% PEG 4000, 5% glycerol) were equilibrated for
two weeks at 291 K. The crystals grew to approximately 0.6 
0.2  0.2 mm.
2.3.2. Data collection. The data set was collected at 100 K
using an Oxford Cryosystems Cryostream on station 14.1 at
the CCLRC Synchrotron Radiation Source, Daresbury
Laboratory, England. The crystal was flash-frozen in cryo-
protectant containing 0.1M Tris–HCl pH 8.5, 0.2M MgCl2,
12% PEG 4000 and 30% glycerol. Diffraction did not extend
beyond 2.9 A˚. Images were processed using MOSFLM
(Leslie, 1999) and the data were scaled using SCALA from the
CCP4 package (Collaborative Computational Project,
Number 4, 1994). The space group is C2221, with unit-cell
parameters a = 117.6, b = 179.5, c = 137.9 A˚ ( =  =  = 90).
There are two subunits in the asymmetric unit; the solvent
content is approximately 60%. Data-collection statistics are
given in Table 1. A randomly selected set of 5% of the terms
was set aside for Rfree-factor validation and was not involved
in any refinement or electron-density map calculation
(Bru¨nger, 1992a).
2.3.3. Molecular replacement, refinement and model
building. Molecular replacement was performed using
MOLREP (Vagin & Teplyakov, 1997) from the CCP4 package
with a preliminary incomplete data set. The dimer of subunits
A and B of G6PDCanton was used as a search model. The
solutions for the two possible orientations of the dimer had
correlation coefficients of 0.53 and 0.52. The next highest
correlation coefficient was 0.39. A partly refined model gave
correlation coefficients of 0.63 and 0.60 for the two dimer
orientations using the complete data set. After rigid-body
refinement with REFMAC5 (Murshudov et al., 1997), the R
and Rfree factors of the initial solution were 41.3 and 41.9%,
respectively. A-weighted 2|Fo|  |Fc| and |Fo|  |Fc| electron-
density maps (Read, 1986) were generated using the CCP4
program suite. Several cycles of manual rebuilding using O
(Jones & Kjeldgaard, 1997) followed by refinement using the
program BUSTER-TNT (Blanc et al., 2004) were carried out.
Water molecules were included at stereochemically sensible
positions in the structure where the electron density was at
least 1 in the 2|Fo|  |Fc| map and at least 3 in the |Fo|  |Fc|
map. The final model, referred to as G6PD–G6P, contains
956 G6PD residues, two G6P molecules, six molecules of
glycerol and 82 water molecules. At convergence, the R and
Rfree factors are 21.2 and 26.1%, respectively, and 85.3% of the
residues lie within the most favoured regions of the Rama-
chandran plot, as defined by PROCHECK (Laskowski et al.,
1993). Refinement details and quality indicators are given in
Table 2.
2.4. NADP+-bound DG6PD in F222
2.4.1. Crystallization, data collection and molecular
replacement. Expression, crystallization, data collection to
2.5 A˚ and structure determination by molecular replacement
of G6PD–NADP+ have previously been reported (Au et al.,
1999). Data-collection statistics are repeated in Table 1.
2.4.2. Refinement and model building. Several cycles of
manual rebuilding using O and X-PLOR (v.3.851; Bru¨nger,
1992b) energy minimization were carried out. In the later
stages of refinement, the program BUSTER-TNT was used.
Water molecules were included at stereochemically sensible
positions in the structure where the electron density was at
least 1 in the 2|Fo|  |Fc| map and at least 3 in the |Fo|  |Fc|
map. The final model contains 489 G6PD residues, one
structural NADP+ molecule, one coenzyme NADP+ molecule,
162 water molecules and two molecules of glycerol. At
convergence, the R and Rfree factors are 19.8 and 29.6%,
respectively, and 87% of the residues lie within the most
research papers
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Table 1
Data-processing statistics of G6P-bound and NADP+-bound G6PD.
Values in parentheses are for the last shell.
G6P-bound G6PD NADP+-bound G6PD
Wavelength (A˚) 1.488 0.87
Space group C2221 F222
Unit-cell parameters (A˚)
a 117.55 60.76
b 179.53 172.48
c 137.94 217.22
G6PD molecules per AU 2 1
Resolution (A˚) 30–2.9 (3.06–2.9) 30–2.5 (2.6–2.5)
Oscillation angle () 1 1
Completeness (%) 98.9 (92.9) 73.3 (59.3)
No. of reflections 503036 115667
No. of unique reflections 32261 18730
Multiplicity 6.8 2.9
I > 3(I) (%) 76.4 (31.3) 66.3 (35.6)
Rmerge (%) 11.8 (41.2) 12.5 (31.4)
Table 2
Refinement statistics and quality indicators of G6P-bound and NADP+-
bound G6PD.
Data set G6P-bound
G6PD
NADP+-bound
G6PD
Resolution (A˚) 30–2.9 30–2.5
Observations in refinement working set 30621 13822
Observations in validation set 1640 726
R factor (%) 21.2 19.6
Rfree (%) 26.1 29.6
Mean B factors (A˚2)
Main-chain atoms 47.5 29.4
Side-chain atoms 54.2 36.2
Water 36.9 30.2
G6P 49.0 —
Coenzyme NADP — 34.0
Structural NADP — 29.5
Glycerol 54.7 33.0
R.m.s.d. distances (A˚) 0.006 0.009
R.m.s.d. bond angles () 0.95 1.03
Ramachandran plot†, residues in
Most favoured regions 85.3 86.8
Additionally allowed regions 14.7 13.2
Generously allowed regions 0 0
Disallowed regions 0 0
† As defined by PROCHECK (Laskowski et al., 1993).
favoured regions of the Ramachandran plot, as defined by
PROCHECK. Refinement details and quality indicators are
given in Table 2.
3. Results and discussion
3.1. Initial rate kinetic properties of DG6PD
G6PD has been cloned and expressed in E. coli and
purified by one-step affinity chromatography using 20,50-ADP
Sepharose. The specific activity of the purified mutant
(190 IU mg1) is similar to that of the recombinant human
wild-type G6PD (180 IU mg1). kcat and Km for NADP+ and
Km for G6P obtained fluorimetrically for G6PD were also
comparable to those of the recombinant human wild-type
enzyme (Wang et al., 2005; Table 3).
3.2. G6P-bound DG6PD structure in C2221
Crystals of G6PD grown in 0.1M Tris–HCl pH 8.5, 0.2M
MgCl2 and 10–14% PEG 4000 in the presence of G6P only
diffracted to 6 A˚. Addition of 5% glycerol to the crystal-
lization buffer greatly increased the resolution limit of the
X-ray diffraction images to 2.9 A˚. The two subunits in the
asymmetric unit are related by a non-crystallographic twofold
axis in the bc plane and at 31 to c. The dimers are related by a
crystallographic twofold axis parallel to a to
form a 222 tetramer.
The crystal was found to contain bound
G6P; the electron density was clearly seen in
each subunit in the initial map (Fig. 2 shows
subunit B). The C-terminus ofG6PD–G6P
is disordered and the final ten residues of
both subunits have been omitted from the
refinement. The conserved prolines 172 and
396 are both found here in the cis conformation. The struc-
tural NADP+ site in the + domain is no more than partly
occupied in either subunit. Since there was no improvement in
Rfree when the structural NADP
+ was included, no structural
NADP+ has been included in the final refinement cycle;
however, the three largest peaks on the final |Fo|  |Fc| map
are close to the anticipated bisphosphate and nicotinamide of
structural NADP+ in subunit B and to the expected bispho-
sphate in subunit A.
There is some evidence that the coenzyme NADP+ site is
also partly occupied in subunit B. The final 2|Fo|  |Fc| and
|Fo| |Fc| electron-density maps show significant density in the
anticipated adenine site, but this is lower than the peaks in the
structural NADP+ site. Electron-density maps for subunit A
gave no indication of coenzyme NADP+ binding, although the
coenzyme-binding site, while more exposed to solvent than
that of subunit B, remains relatively ordered. No coenzyme
NADP+ has been included in refinement.
The bound G6P is well ordered and its displacement para-
meters are similar to those of its protein ligands. The
hydrogen-bonding network in the substrate-binding site of
G6PD–G6P is shown in Fig. 3. In common with the G6P-
bound LM G6PD (LM G6PD–G6P) complex (Cosgrove et al.,
2000), G6P is bound in the pocket between domains. Most of
the residues of G6PD that interact with G6P are conserved
and correspond to those in LM G6PD–G6P.
A distinction can be made between the edge of G6P that
approaches the coenzyme domain, which includes the
hydroxyl atom (O1) to be oxidized, and the edge that
approaches the large mixed -sheet. In addition to atom O1,
phosphate atoms O6 and O8, ring atom O5 and hydroxyl atom
O2 face the coenzyme domain. Contacts are preserved
between human G6PD and LM G6PD for these atoms.
Tyr202 (179)1, His201 (178) and Lys205 (182) from the highly
conserved peptide sequence at the domain boundary interact
with phosphate O atoms, while Asp258 (235) contacts O2 and
O3, and His263 (240) N"2 contacts O1.
The mutant LM G6PD H178N showed dramatic increases
in Km and Kd for G6P and a loss of the ability to discriminate
between G6P and d-glucose (Cosgrove et al., 1998). Mutations
K205R and K205Twere shown to affect kcat primarily and thus
to be essential for catalysis in human G6PD (Bautista et al.,
1995). A different result was found for LM G6PD, where Km
was primarily affected on mutagenesis of Lys182 (Vought et
al., 2000). The two-point interaction of Asp258 is also seen in
research papers
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Table 3
Dalziel parameters and their ratios for the reaction catalysed by wild-type G6PD (G6PDWT;
Wang et al., 2005) and G6PD.
Enzyme ’0 (s) ’NADP
(mM s)
’G6P
(mM s)
’NADP–G6P
(mM2 s)
kcat
(s1)
KmNADP
(mM)
KmG6P
(mM)
kcat/KmNADP
(mM1 s1)
kcat/KmG6P
(mM1 s1)
G6PD WT 0.0037 0.0259 0.191 1.61 275 7.07 52 39.7 5.31
G6PD 0.0042 0.0271 0.175 1.55 208 6.45 42 32.3 5.02
Figure 2
Electron density for bound G6P seen in the initial G6PD–G6P map.
The 2|Fo| |Fc| density is contoured at 1. Neighbouring residues that are
conserved are labelled in blue. Sheet strands are identified as in Fig. 1.
1 Residue numbers in roman type are for the human enzyme; those in italics
are for the L. mesenteroides enzyme.
LM G6PD–G6P (Cosgrove et al., 2000). In G6PD–G6P,
atom O1 of G6P is 2.9 A˚ from the N"2 atom of His263; N1 of
this residue hydrogen bonds with Asp200 O1. This interaction
is the same as that seen in LM G6PD, where His240 is the
general base for catalysis and Asp177 and His240 form the
catalytic dyad (Cosgrove et al., 2000). The mutation of H240N
in LM G6PD caused a decrease in kcat of the enzyme by a
factor of 105 (Cosgrove et al., 1998). There is, however, one
significant difference in the contacts with O1 in the two
species. In G6PD, Lys171, the second residue of the
conserved EKPxG peptide, is seen to interact with O1 and O2
of G6P in subunit B, although it is not well ordered. In
contrast, no density can be seen for the side chain of Lys149 of
LM G6PD–G6P.
Differences are seen between the two species in binding the
edge of G6P, which interacts with the mixed -sheet, even
though some of the residues involved are conserved. In
G6PD–G6P, Arg365 and Gln395 interact with phosphate O
atoms. Arg365 hydrogen bonds directly with phosphate atom
O7 and interacts indirectly with phosphate atom O9 via a
water molecule, while in LM G6PD–G6P the equivalent
Lys343 interacts with phosphate atom O9 (Cosgrove et al.,
2000). The interaction of Gln395 (Asp374) with the phosphate
of G6P is not conserved. Lys360 (338) bridges atoms O3 and
O4 in G6PD, while only atom O3 is involved in LM G6PD.
Glu239 (216) interacts with O4 in both species, but Arg246
(223) is disordered inG6PD while it is a ligand in LMG6PD.
The main chain of Arg246 is far enough away from G6P to
preclude an equivalent interaction. Glu239, Lys360 and
Arg365 are close to the ends of the sheet strands G, I and
K, respectively.
3.3. NADP+-bound DG6PD structure in F222
The G6PD–NADP+ binary complex crystallizes in space
group F222 with one G6PD subunit in the asymmetric unit.
The molecule forms a tetramer with crystallographic 222
symmetry. Prolines 172 and 396 are again in the cis confor-
mation.
NADP+ is bound to both the coenzyme site and the struc-
tural NADP+ site, even though no additional NADP+ was
present in the crystallization solution. Both the structural and
the coenzyme NADP+s have full occupancy and are well
ordered with displacement parameters close to those of the
surrounding protein; those for the coenzyme NADP+ are
higher than for the structural NADP+. Coenzyme NADP+ is
shown in the final 2|Fo|  |Fc| electron-density map of the
region in Fig. 4(a). The molecule is positioned similarly to
NADP+ in the LM G6PD–NADP+ complex (Naylor et al.,
2001). NADP+ binds with the adenine ring in the anti
conformation and the two ribose rings and the bisphosphate
span the C-terminus of the -sheet of the coenzyme domain.
In the built conformation, the nicotinamide approaches O1 of
G6P. In a possible alternative conformation, the nicotinamide
ribose is rotated and the nicotinamide is rotated again so that
it remains in the entrance to the active-site cleft and is not in
the correct position for catalysis. In its built position, the
coenzyme conformation resembles that in LM G6PD; in the
alternate position, it is less open.
Protein–coenzyme NADP+ interactions are shown in
Fig. 4(b). There are hydrogen bonds from the adenine ribose
30-hydroxyl and the bisphosphate O atoms to the main-chain
amino groups of Gly41 and Asp42 of the nucleotide-binding
fingerprint (GASGDLA) in the A–a turn. The nicotin-
amide ribose 20-hydroxyl group forms a hydrogen bond to the
research papers
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Figure 3
The hydrogen-bonding network in the substrate site of (a) G6PD–G6P
and (b) LM G6PD. C atoms of G6P are drawn in cream; those of residues
interacting with G6P are drawn in cyan. Potential hydrogen bonds are
indicated by dotted lines. Those that directly involve atoms of the
substrate are drawn in pink; others are in cyan. Neighbouring residues
that are conserved are labelled in blue.
carbonyl group of Lys171, one of the residues of the E–e
turn (residues 170–176). Arg72 interacts with the 20-phos-
phate, with hydrogen bonds made by both the N" and N2
atoms of the arginine to a phosphate O atom. The hydroxyl
group of Tyr112 also hydrogen bonds to this phosphate O
atom; in LM G6PD, the equivalent residue is Val86 and this
interaction cannot occur. A second phosphate O atom makes
a hydrogen bond to Ser73 O; the interaction is not possible
forGln47 of LMG6PD. A hydrogen bond to Ser40 O mirrors
that with the equivalent Thr14 O1 of LM G6PD–NADP+
(Naylor et al., 2001).
The environment of the adenine is surprisingly different
between the G6PD–NADP+ and LM G6PD–NADP+
complexes (Fig. 4c). Two regions shield the adenine ring from
solvent in LM G6PD (Naylor et al., 2001). The first, proximal
to the 20-phosphate, comprises Ala45 (71) and Arg46 (72) and
is retained to a large extent. However,Gln47 (Ser73) is poorly
conserved (60% Ser or Thr and only 5% Gln) and the
differing side-chain lengths affect packing around the adenine
and adenine ribose. The face of the adenine distal to the
20-phosphate is affected by the region 110–112 (84–86). In
human G6PD, the sequence is Gly-Gln-Tyr, while in LM
G6PD it is His-Asp-Val. The hydrogen bond between
Tyr112 O and the 20-phosphate forces the adenine ring to
approach the solvent, while in the LM G6PD–NADP+
complex Val86 makes a hydrophobic surface for the adenine
and further contacts are made with the side chain of Asp85
and the main chain of His84. In both species there is some
contribution from Leu142 and Val146 (Val118 and Phe122) in
the D–D turn; Pro143 (Ala119) is also involved in G6PD
but not in LM G6PD. The more hydrophobic environment for
the adenine ring in the LM G6PD complex may be a signifi-
cant contribution to dual coenzyme specificity in that species.
3.4. The G6PD tetramer
Mean coordinate differences between the crystallo-
graphically independent subunits of these structures and the
subunits of the ABCD tetramer in G6PDCanton are given in
Table 4. The two subunits of G6PD–G6P are very similar.
The main differences at the subunit level between either
G6PD or G6PDCanton, other than at the N- and C-termini,
correspond to the changes consequent on the change of
Pro172 from trans in G6PDCanton to cis in both G6PD
structures. Additionally, helix b is longer and better ordered
in G6PD.
The larger differences seen for dimer-to-dimer alignments
relate to slightly different hinge angles between coenzyme and
+ domains, particularly when coenzyme is present; the
coenzyme domains are at the greatest distance from the 222
centre. The hinge-angle differences are much smaller than
those that were seen in LM G6PD complexes (Naylor et al.,
2001).
The relatively small tetramer contact involves two surfaces
close to the 222 centre. Although the interface surfaces are not
identical in the three space groups, the contact regions are
very similar and many of the same residues, at the junction of
i and j, on j and in the I–J and K–L loops, are
important. The contacts are predominantly polar; each subunit
contains eight basic and ten acidic residues with functional
groups less than 10 A˚ apart across the interface.
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Figure 4
(a) Final 2|Fo| |Fc| map forG6PD–NADP+ in the region of the coenzyme NADP+. Electron density corresponding to the protein is in grey, contoured
at 1.2. Density for NADP+ is in blue, contoured at 0.9. (b) Potential hydrogen-bond interactions for the coenzyme NADP+ in G6PD–NADP+. (c)
Potential hydrogen bonds for the coenzyme NADP+ in LM G6PD–NADP+. Interactions and direct contacts are to both backbone and side chains of
surrounding residues. Interactions mediated by water molecules (in green) are also shown. The coenzyme lies in a classic ‘Rossmann-fold’, with residues
38–44 as the binding fingerprint. The G6PD sequence does not contain the extended motif recently identified in other nucleotide-binding proteins
(Kleiger & Eisenberg, 2002).
The salt-bridge interactions between Lys275 and Glu347
and between Lys290 and Glu287 observed in G6PDCanton are
not preserved, although these residues remain close in both
G6PD complexes. The dimers of G6PD–G6P have moved
apart slightly to accommodate a glycerol which contacts
Glu347 and this change probably accounts for both the
increased order in the presence of glycerol and the increase in
mean coordinate differences when the tetramer is aligned with
either G6PDCanton or G6PD–NADP
+. In G6PD–NADP+,
there are ordered water molecules in the interface and an
alternative salt bridge is made between subunits by Asp283
and Lys293, one turn earlier and one turn later in the helices j
from the two subunits.
Our different structures suggest the flexible polar inter-
actions are responsible for the dimer–tetramer equilibrium
and its sensitivity to ionic strength (Bonsignore et al., 1971;
Wrigley et al., 1972). The biological importance of this equi-
librium remains obscure; human G6PD is active as either
dimer or tetramer.
3.5. Proline 172
The conserved Pro172 (149), the central residue of the
conserved EKPxG peptide, has been found in the cis confor-
mation in both G6PD complexes, while in the uncomplexed
G6PDCanton structure the residue is trans in seven out of eight
subunits. In LM G6PD, Pro149 has been shown to be cis in all
binary complexes (Cosgrove et al., 1998, 2000; Naylor et al.,
2001), but trans for one subunit of the dimer in the absence of
substrate or coenzyme (Rowland et al., 1994). The approach of
the substrate and the coenzyme and the proximity of the
conserved EKPxG peptide in the G6PD structures are seen
in Fig. 5. The trans–cis isomerization of Pro172 results in a
movement of the helix e, allowing Lys171 to interact with
G6P O1 through the terminal amino group and with the
nicotinamide ribose 30-hydroxyl of NADP+ through its
carbonyl group. In LM G6PD the mutations P149G and
P149V greatly reduced the kcat values of
the mutant and affected all the kinetic
constants and the dissociation constant for
G6P (Vought et al., 2000). The human
mutant P172S (Volendam) exhibits class 1
deficiency, while the isolated enzyme has
reduced specific activity and the highest
Km value for G6P for any G6PD mutant
(Roos et al., 1999). These results suggest
that Pro172 is directly involved in the
correct positioning of the substrate and
coenzyme pockets. Mutation to residues
that are unable to adopt a cis conformation
would lead to an extremely high activation-
energy barrier for the enzyme to adopt the
correct transition state during the enzy-
matic reaction.
3.6. The structural NADP+ site
The structural NADP+ site is only found
and conserved in higher organisms. The
increased number of replacements and the
shortened C-terminal tail in prokaryotic
G6PD implies the absence of the site (data
not shown); it is not present in LM G6PD.
The evolutionary significance of this site is
still unknown. However, the large number
of class 1 mutants clustered in the struc-
tural NADP+ site and also the presence of
several mutants that can be reactivated by
increased NADP+ concentration (Beutler
et al., 1991) suggested that the binding of
NADP+ is important for the enzymatic
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Table 4
Mean coordinate differences (A˚), for all equivalent atoms, between
different molecules.
Alignment G6PD–
G6P
G6PD–
NADP+
G6PDCanton
G6P–G6P Monomer–monomer 0.58 0.89 0.95
G6P–G6P Dimer–dimer 1.50 1.20
G6P–G6P Tetramer–tetramer 2.43 1.91
G6PD–NADP+ Dimer–dimer 1.40
G6PD–NADP+ Tetramer–tetramer 1.58
Figure 5
Stereoview of the proximity of coenzyme and substrate. The coenzymes seen in G6PD–
NADP+ and G6P, superimposed from the G6PD–G6P structure, are drawn with C atoms
coloured cream. Residues important in binding or catalysis are drawn in cyan; other portions of
the chain are drawn in black. Also superimposed (in green) are residues 170–172 (EKP) from
subunit A of G6PDCanton, in which Pro172 is trans; the effect on Lys171 of the change to cis
Pro172 in G6PD–NADP+ and G6PD–G6P is evident.
activity in higher organisms and that this region is sensitive to
changes in NADP+ concentration. Many studies (e.g. Scopes et
al., 1998) have shown the lower thermal stabilities and
differing sensitivity to low NADP+ concentration of mutant
enzymes with changes close to the structural NADP+ site.
In G6PD–NADP+, well ordered NADP+ is seen in the
structural NADP+ site between the -sheet and C-terminus of
the monomer. It is shown in the final electron-density map of
the region (Fig. 6a). As in G6PDCanton (Au et al., 2000), the
NADP+ is effectively buried in the protein, occupying a
crevice which is positively charged. The contacts of the protein
to the NADP+ (Fig. 6b) are essentially the same as those seen
in G6PDCanton and are all made by side-chain atoms of the
subunit. There are six water molecules that make contact with
the NADP+; the G6PDCanton structure was of too low a reso-
lution for them to have been included in the refinement. Two
contacts are changed from G6PDCanton: the interaction of both
Arg357 and Glu364 with the 20-phosphate is mediated by
water molecules in G6PD. Lys238 N, while close to the
20-phosphate, interacts with Asn363, which itself interacts with
a third water molecule bound to the 20-phosphate.
In G6PD–G6P, the structural NADP+ is bound in less
than half the molecules. There is little difference between the
subunits either in the nature of the site or in the evidence for
bound NADP+. Both structural NADP+s were omitted from
the final structure, although the final electron-density maps
gave evidence of some binding with a small movement from its
position in G6PDCanton or in G6PD–NADP
+. A modelled
NADP+ molecule, optimally positioned in the G6PD–G6P
structure, is shown superposed on the final 2|Fo|  Fc| and the
difference density of subunit B in Fig. 7.
The absence of an ordered C-terminal region and the poor
binding of the structural NADP+ are correlated. The nicotin-
amide ring could not be stabilized in G6PD–G6P since
Trp509 is not ordered. In the absence of the nicotinamide ring,
the two Asp421 side chains of the dimer have rotated and
interact across the interface through a single water molecule.
Much of the binding pocket for this part of the structural
NADP+ has been lost in this complex and any bound NADP+
is exposed to solvent. The low occupancy of the structural
NADP+ site suggests a dynamic equilibrium and that the
molecule may migrate to the coenzyme site if NADP+ in
solution has been depleted. This may result in the observed
flexibility of the C-terminal ten residues or the potential for
flexibility may be necessary for NADP+ migration. Movement
of the C-terminal tail is possible with Gly505 acting as a hinge;
a group of negatively charged residues (Glu416, Glu417 and
Glu419) is exposed to the surface when the tail is mobile
(Figs. 6a and 7). In a closed system with a large excess of G6P,
where the NADP+ is essentially all reduced to NADPH, some
NADPH may bind at the structural NADP+ site; however, the
binding will be less tight than that of NADP+ as the reduced
nicotinamide ring, with a pyramidal ring N atom and limited
-electron delocalization, is unable to form – interactions
with Tyr401 and Trp509. It follows that,
if the C-terminal ten residues are
disordered in the absence of the
structural NADP+, NADPH is not
likely to reorder them. Furthermore,
the exposed negatively charged patch
may attract the positive charge on the
oxidized nicotinamide ring to the
general area of the binding site while
the more negatively charged NADPH is
not attracted to it.
The tightness of binding of NADP+
to the structural NADP+ site may also
be affected by G6P binding at the
distant G6P site. Although the G6P site
is situated some 15 A˚ from the struc-
tural NADP+, the two sites are on
opposite faces of the large mixed
-sheet (Fig. 8). The most effective way
in which the presence of G6P can be
signalled to the NADP+ site is through
groups of residues which are close in the
sequence but span from one binding site
to the other. There are three sets of
residues of this kind. The most exten-
sive cross-connection is in the loop
between sheet strands J and K and at
the beginning of that strand. In this
loop, Asn363 and Glu364 contact bound
water molecules, which are themselves
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Figure 6
(a) Final 2|Fo| – |Fc| map for G6PD–NADP
+ in the region of the structural NADP+. Electron
density for most of the molecule is in grey and is contoured at 1.25. Density for the C-terminal
region from 503 is in cyan and is contoured at 1. Density for NADP+ is in blue and is contoured at
1.0. Residues shown in black are in one subunit of the dimer; those in red are in the other. (b)
Potential hydrogen bonds for the structural NADP+ in G6PD–NADP+. Interactions and direct
contacts are either with the side chains of surrounding residues or to water molecules (shown in
green). The changes in the conformation of NADP+ inG6PD when bound in the structural site or
in the coenzyme site (Fig. 4b) are clear.
ligands to the 20-phosphate of the structural NADP+; Arg365
binds the phosphate of G6P while Lys366 at the beginning of
the sheet again interacts with the 20-phosphate of the struc-
tural NADP+. At the end of the adjacent sheet strand G,
Lys238 also interacts indirectly with the structural NADP+,
while Glu239 forms a hydrogen bond to atom O4 of G6P. In
the third strand, Gln395, at the end of L, is a G6P phosphate
ligand, while Arg393, within the sheet strand, interacts with
the NADP+ nicotinamide amide O atom. The three groups of
residues on opposite faces of the adjacent sheet strands G,
K and L are thus well placed to relay the presence of G6P
across the mixed -sheet.
It has already been noted that the two residues 365 and 395
are not conserved for all species. Of the residues discussed
above, only Glu239 and Pro396 are fully conserved, while
Gln395 is 96% conserved; the importance of these last three
residues in binding G6P and in defining the shape of the
binding site is thus underlined. The specificity for structural
NADP+ is apparent in that four of the residues involved in the
cross-connection are 20-phosphate ligands: Lys366 directly and
Lys238, Asn363 and Glu364 through water molecules.
The significance of the region connecting the two binding
sites in fine-tuning the activity of human G6PD is also indi-
cated by the number of severe variants found among the
above residues, particularly those relevant to NADP+ binding.
Durham K238R, Aachen and Loma Linda N363K (nucleotide
1089 C to G and C to A, respectively), Wisconsin R393G,
Nashville (Anaheim, Calgary, Portici) R393H, Alhambra
V394L and Bari P396L are all class I variants. While our
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Figure 8
Residues bridging from the G6P site to the structural NADP+ site The
same view is used to allow comparison of this region in (a)G6PD–G6P
and (b)G6PD–NADP+. Sheet strands are drawn in green and identified
as in Fig. 1. Class I variants arise on mutation of those residues labelled in
magenta.
Figure 7
Modelled structural NADP+ molecule in subunit B of G6PD–G6P. The
final 2|Fo|  |Fc| map, drawn in grey, is contoured at 1.25. The difference
electron density, in blue, is contoured at 2.5. NADP+ was not included in
Fc. Residues shown in black are in subunit B; those in red are in subunit
A. Comparison with Fig. 6(a) shows the exposure of charged residues in
sheet strand N when the residues of the tail are removed and the change
in position of the side chain of both A421 and B421 in the absence of well
bound NADP+.
results can be explained by reduction of all NADP+ to
NADPH, the possibility of an interaction between bound G6P
and the NADP+ site, lowering the affinity for NADP+ at the
structural site, cannot be discounted. However, there is little
movement of the side chains of the residues involved in the
communication between G6P and structural NADP upon
binding to the substrates. Measurements of the dissociation
constant of the structural NADP+ in the wild-type enzyme and
in certain mutants are under way (personal communication
from P. C. Engel) and are to be followed by an investigation of
NADPH. Any change of affinity of NADP+ or NADPH upon
G6P binding will shed further light on the details of human
G6PD stability and activity.
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